ANDA 87075, held by Mallinckrodt. Diatrizoate Sodium.
As of Nov 16, 2026, ANDA 87075 (Md-50), held by Mallinckrodt, was not approved, with 2 approved supplements and 0 published complete response letters.
| Product | Active ingredient | Marketing |
|---|---|---|
| Md-5050% ยท injectable;injection | Diatrizoate Sodium | Discontinued |
| Feb 4, 1987 | Supplement 5Manufacturing | Approved | None posted |
| Nov 15, 1984 | Supplement 4Manufacturing | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters